In this issue:
Neoadjuvant therapy improves survival in resectable PaC
Timing of adjuvant chemotherapy in resected PaC
Using dose-modified FOLFIRINOX in PaC
mFOLFOX6 in the second-line setting for PaC
Everolimus for advanced pancreatic neuroendocrine tumours?
A biomarker-integrated targeted therapy approach
Impact of increasing age on lung cancer mortality
Alectinib active in CNS in crizotinibrefractory ALK+ NSCLC
Cabazitaxel active in docetaxelresistant NSCLC
Comparing neoadjuvant approaches in gastric cancer
Please login below to download this issue (PDF)